Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY.
Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY.
J Stroke Cerebrovasc Dis. 2022 Dec;31(12):106847. doi: 10.1016/j.jstrokecerebrovasdis.2022.106847. Epub 2022 Oct 28.
It is poorly understood if endovascular thrombectomy (EVT) with or without intravenous thrombolysis (IVT) better facilitates clinical outcomes in patients with acute basilar artery occlusion (BAO) ischemic stroke.
A systematic literature review and meta-analysis was completed to investigate the outcomes of EVT with IVT versus direct EVT alone in acute BAO. Data was collected from the literature and pooled with the authors' institutional experience. The primary outcome measure was 90-day modified Rankin sale (mRS) of 0-2. Secondary measures were successful post-thrombectomy recanalization defined as mTICI ≥2b, 90-day mortality, and rate of symptomatic ICH.
Our institutional experience combined with three multicenter studies resulted in a total of 1,127 patients included in the meta-analysis. 756 patients underwent EVT alone, while 371 were treated with EVT+IVT. Patients receiving EVT+IVT had a higher odds of achieving a 90-day mRS of ≤ 2 compared to EVT alone (OR: 1.50, 95% CI 1.15 to 1.95, P =0.002, I =0%). EVT+IVT also had a lower odds of 90-day mortality (OR: 0.57, 95% CI 0.37 to 0.89, P=0.01, I=24%). There was no difference in sICH between the two groups (OR: 1.0, 95% CI: 0.56 to 1.79, P=0.99, I=0%). There was also no difference in post-thrombectomy recanalization rates defined as mTICI ≥2b (OR: 1.11, 95% CI 0.70 to 1.75, P = 0.65, I=37%).
On meta-analysis, EVT with bridging IVT results in superior 90-day functional outcomes and lower 90-day mortality without increase in symptomatic ICH. These findings likely deserve further validation in a randomized controlled setting.
目前尚不清楚血管内血栓切除术(EVT)联合或不联合静脉溶栓(IVT)是否能改善急性基底动脉闭塞(BAO)缺血性脑卒中患者的临床结局。
系统地对 EVT 联合 IVT 与单独 EVT 治疗急性 BAO 的结果进行了文献综述和荟萃分析。数据来自文献,并结合作者机构的经验进行了汇总。主要观察指标为 90 天改良 Rankin 量表(mRS)评分 0-2 分。次要观察指标为血栓切除术后再通定义为 mTICI≥2b、90 天死亡率和症状性 ICH 发生率。
我们机构的经验加上三项多中心研究,共纳入 1127 例患者进行荟萃分析。756 例患者接受单独 EVT 治疗,371 例患者接受 EVT+IVT 治疗。与单独 EVT 治疗相比,接受 EVT+IVT 治疗的患者 90 天 mRS 评分≤2 的可能性更高(OR:1.50,95%CI 1.15-1.95,P=0.002,I=0%)。EVT+IVT 治疗 90 天死亡率也更低(OR:0.57,95%CI 0.37-0.89,P=0.01,I=24%)。两组间症状性 ICH 发生率无差异(OR:1.0,95%CI:0.56-1.79,P=0.99,I=0%)。血栓切除术后再通率(mTICI≥2b)也无差异(OR:1.11,95%CI 0.70-1.75,P=0.65,I=37%)。
荟萃分析结果表明,血管内血栓切除术联合桥接静脉溶栓可改善 90 天的功能结局,降低 90 天死亡率,且不增加症状性 ICH。这些发现可能需要在随机对照试验中进一步验证。